Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-Cyanocyclohexaneacetic acid is an organic compound with the molecular formula C8H11NO2. It is a derivative of cyclohexaneacetic acid, featuring a nitrile group (CN) and a carboxyl group (COOH) attached to the cyclohexane ring. 1-Cyanocyclohexaneacetic acid is known for its unique chemical properties and potential applications in various industries.

133481-09-1

Post Buying Request

133481-09-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

133481-09-1 Usage

Uses

Used in Pharmaceutical Industry:
1-Cyanocyclohexaneacetic acid is used as a Gabapentin analogue for the treatment of neurological disorders. It serves as a key intermediate in the synthesis of Gabapentin, a widely prescribed medication for conditions such as epilepsy, neuropathic pain, and restless legs syndrome. The compound's structural similarity to Gabapentin allows it to potentially modulate neuronal activity and alleviate symptoms associated with these disorders.
Used in Chemical Synthesis:
1-Cyanocyclohexaneacetic acid can be utilized as a building block in the synthesis of various chemical compounds, particularly those with pharmaceutical or industrial applications. Its unique functional groups, including the nitrile and carboxyl groups, enable it to participate in a range of chemical reactions, such as hydrolysis, reduction, and amide formation, allowing for the creation of diverse molecular structures.
Used in Research and Development:
As a novel compound with potential applications in various fields, 1-Cyanocyclohexaneacetic acid can be employed in research and development efforts to explore its properties, reactivity, and potential uses. This may involve studying its interactions with other molecules, evaluating its stability under different conditions, and investigating its potential as a precursor to other valuable compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 133481-09-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,4,8 and 1 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 133481-09:
(8*1)+(7*3)+(6*3)+(5*4)+(4*8)+(3*1)+(2*0)+(1*9)=111
111 % 10 = 1
So 133481-09-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H13NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-6H2,(H,11,12)

133481-09-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (Y0001348)  Gabapentin impurity B  European Pharmacopoeia (EP) Reference Standard

  • 133481-09-1

  • Y0001348

  • 1,880.19CNY

  • Detail
  • USP

  • (1287347)  Gabapentin Related Compound B  United States Pharmacopeia (USP) Reference Standard

  • 133481-09-1

  • 1287347-30MG

  • 14,578.20CNY

  • Detail

133481-09-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(1-cyanocyclohexyl)acetic acid

1.2 Other means of identification

Product number -
Other names Gabapentin impurity B

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:133481-09-1 SDS

133481-09-1Relevant articles and documents

Nitrilase-catalyzed selective hydrolysis of dinitriles and green access to the cyanocarboxylic acids of pharmaceutical importance

Zhu, Dunming,Mukherjee, Chandrani,Biehl, Edward R.,Hua, Ling

, p. 1667 - 1670 (2007)

To further explore its synthetic applications, the nitrilase bll6402 from Bradyrhizobium japonicum strain USDA110 has been examined toward the hydrolysis of various dinitriles. It has been found that nitrilase bll6402 effectively hydrolyzed α,ω-dinitriles to ω-cyanocarboxylic acids, and the selectivity was independent of the substrate chain length. This feature is distinct from all the known nitrilases of various sources. Nitrilase bll6402 was thus applied to the synthesis of 1-cyanocycloalkaneacetic acids, the useful precursors for the synthesis of gabapentin and its analogues.

Enzymatic production of key intermediate of gabapentin by recombinant amidase from Pantoea sp. with high ratio of substrate to biocatalyst

Wu, Zhe-Ming,Zheng, Ren-Chao,Ding, Xu,Jin, Jian-Qiang,Zheng, Yu-Guo

, p. 607 - 613 (2016)

1-Cyanocyclohexaneacetic acid is the key intermediate of gabapentin. A novel bioprocess catalyzed by amidase was developed for efficient production of 1-cyanocyclohexaneacetic acid from 1-cyanocyclohexaneacetamide, which can be prepared with high efficiency by nitrile hydratase-catalyzed regioselective hydration of 1-cyanocyclohexaneacetonitrile. Kinetic analysis and molecular docking of three recombinant amidase demonstrated that amidase (Pa-Ami) from Pantoea sp. was the most robust biocatalyst for hydrolysis of 1-cyanocyclohexaneacetamide with the kcat/Km value of 208.2 ± 16.2 mM-1 s-1. Some key parameters of the bioprocess, such as substrate loading, catalyst loading and product inhibition, were investigated. Enzymatic hydrolysis of 80 g/L of 1-cyanocyclohexaneacetamide was completed within 20 min using 1 g/L wet whole cells of recombinant Escherichia coli BL21, leading to high ratio of substrate to catalyst (S/C-ratio, 80) and high space-time yield (5794.7 gproduct L-1 d-1). These encouraging results indicated the great potential of Pa-Ami in practical production of gabapentin.

Chemoenzymatic synthesis of gabapentin by combining nitrilase-mediated hydrolysis with hydrogenation over Raney-nickel

Xue, Ya-Ping,Wang, Ying-Peng,Xu, Zhe,Liu, Zhi-Qiang,Shu, Xin-Rui,Jia, Dong-Xu,Zheng, Yu-Guo,Shen, Yin-Chu

, p. 121 - 125 (2015)

An efficient chemoenzymatic process is devised for synthesizing high-purity gabapentin. 1-Cyanocyclohexaneacetic acid was first produced in 0.94 M from 1.0 M 1-cyanocycloalkaneacetonitrile by a greatly improved nitrilase from Acidovorax facilis ZJB09122, resulting in a commercially attractive bioprocess with an outstanding space-time yield of 461 g/L/day. The resulting aqueous 1-cyanocycloalkaneacetic acid was then directly converted to 2-azaspiro [4.5] decan-3-one without further purification in subsequent hydrogenation by Raney-nickel, followed by simple chemical steps to afford gabapentin in high purity and 77.3% overall yield from 1-cyanocyclohexylacetonitrile. The simplicity of the process makes this new pathway suitable for large-scale preparation.

A PROCESS FOR THE PREPARATION OF GABAPENTIN

-

Page/Page column 22, (2014/01/09)

The present invention provides an improved process for the preparation of a compound of formula (I),

PROCESS FOR PREPARING GABAPENTIN

-

Page/Page column 17, (2008/06/13)

A process for preparing gabapentin of formula 1, which comprises Formula (I) converting 1-allyl-cyclohexanecarboxaldehyde into 1-allyl-cyclohexanecarbonitrile; ozonizing 1-allyl-cyclohexanecarbonitrile to obtain 1-cyano-cyclohexaneacetaldehyde; acetalizing 1-cyano-cyclohexaneacetaldehyde with a suitable acetalizing agent to give the corresponding acetal and converting the latter into gabapentin.

Process for preparing a cyclic amino acid anticonvulsant compound

-

, (2008/06/13)

An improved process for the preparation of a cyclic amino acid by a novel synthesis is described where benzonitrile is treated with an alkali metal and an amine under Birch reduction conditions to generate in situ an anionic intermediate which is alkylated with an α-haloacetic acid moiety which is subsequently converted to the desired product, as well as valuable intermediates used in the process.

Process for cyclic amino acid anticonvulsant compounds

-

, (2008/06/13)

An improved process for the preparation of cyclic amino acids by a novel synthesis is described where a dinitrile derivative is converted in two steps to the desired products, as well as valuable intermediates used in the process.

Process for cyclic amino acid anticonvulsant compounds

-

, (2008/06/13)

An improved process for the preparation of cyclic amino acids by a novel synthesis is described where a dinitrile derivative is converted in two steps to the desired products, as well as valuable intermediates used in the process.

Process for the preparation of cyclic amino acids and intermediates useful in the process

-

, (2008/06/13)

Processes for the preparation of cyclic amino acid derivatives useful in the treatment of cerebral diseases such as epilepsy are disclosed. Novel intermediates useful in processes are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 133481-09-1